BOULDER, CO, UNITED STATES, October 8, 2025 /EINPresswire.com/ -- Faex Health, a fast-growing digital health startup, today announced the release of its C. difficile ...
Citing potential disclosure requirements from the Food and Drug Administration, lack of insurance coverage and lack of support among clinicians, the founders of stool-donation initiative, OpenBiome, ...
C. diff, which is short for Clostridioides difficile, is a type of bacteria that may cause serious problems in the digestive system. It is one of the most common causes of diarrhea linked to ...
Clostridium difficile bacteria, computer illustration. C. difficile is a normal inhabitant of the human intestine, but it can become a pathogen when antibiotics disrupt the normal intestinal flora and ...
A new Cochrane Review led by an Upstate Medical University professor has found that, compared with standard antibiotic treatment, stool transplantation can increase the number of people recovering ...
Costly treatments from Merck & Co and other drugmakers, and a vaccine from Sanofi, are on the horizon. But growing numbers of gastroenterologists are more excited about the use of human stool ...
Fecal microbiota transplantation has become one of the most effective treatments for recurrent Clostridioides difficile infections, but its long-term role in gastroenterology may hinge on moving ...
TUESDAY, August 5, 2025 (HealthDay News) — C. diff, which is short for Clostridioides difficile, is a type of bacteria that may cause serious problems in the digestive system. It is one of the most ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback